MB
MAYA BOLTER
FAEGRE DRINKER BIDDLE & REATH LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
2
last 3 years
Filings
4
6 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Legislative Intern
Representative Dean Phillips (D-MN-03), September 2010-December 2019
Disclosed on LD-2 filings
Legislative Intern
Representative Dean Phillips (D-MN-03), September 2019-December 2019
Disclosed on LD-2 filings
Career
FD
Specific issues
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Research funding and therapy development.